title: Sugammadex in anaphylaxis - a case-control study? A reply.
authors.affiliation: Sir Charles Gairdner Hospital, Perth, Australia. peter.platt@uwa.edu.au.
authors.forename: P
authors.initials: P
authors.lastname: Platt
authors.affiliation: Sir Charles Gairdner Hospital, Perth, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Sadleir
authors.affiliation: Sir Charles Gairdner Hospital, Perth, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Clarke
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy*; D000732:Androstanols / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D006801:Humans; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D047408:gamma-Cyclodextrins / Q000494:pharmacology*
chemical_list: D000732:Androstanols; D000900:Anti-Bacterial Agents; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins